Showing results (811-820 of 2,733) with videos related to
Sort By:
Pageof 274
Pharmacogenomics|October 8, 2019
Letter to the editor: reply to Bousman et al.Graeme K Suthers, Tom M PolasekPharmacogenomics|October 8, 2019
A stepwise approach to implementing pharmacogenetic testing in the primary care settingKristin Wiisanen Weitzel, Benjamin Q Duong, Meghan J Arwood, et al.Pharmacogenomics|September 12, 2022
A survey of physician opinions in Russia in the field of pharmacogenetics of cardiovascular diseaseDmitry Sychev, Ludmila Fedina, Maria Poptsova, et al.Pharmacogenomics|August 31, 2022
Detection of relevant pharmacogenetic information through exome sequencing in oncologySimon Verdez, Juliette Albuisson, Yannis Duffourd, et al.Pharmacogenomics|November 3, 2022
Pharmacogenomics of medications given via nonconventional administration routes: a scoping reviewSamantha Socco, Dyson T Wake, James C Lee, et al.Pharmacogenomics|June 13, 2015
Release of (and lessons learned from mining) a pioneering large toxicogenomics databaseKomal S Sandhu, Vamsi Veeramachaneni, Xiang Yao, et al.Pharmacogenomics|June 19, 2015
ABCG2 gene polymorphisms as risk factors for atorvastatin adverse reactions: a case-control studyNikica Mirošević Skvrce, Viola Macolić Šarinić, Iveta Šimić, et al.Pharmacogenomics|July 28, 2016
Genetic polymorphisms influence on the response to clopidogrel in peripheral artery disease patients following percutaneous transluminal angioplastyXando Díaz-Villamarín, Cristina Lucía Dávila-Fajardo, Luis Javier Martínez-González, et al.Pharmacogenomics|June 27, 2015
Effects of IGF2BP2, KCNQ1 and GCKR polymorphisms on clinical outcome in metastatic gastric cancer treated with EOF regimenXin Liu, Zhiyu Chen, Xiaoying Zhao, et al.Pharmacogenomics|June 20, 2020
Effects of EPHX1 rs2260863 polymorphisms on warfarin maintenance dose in very elderly, frail Han-Chinese populationXianliang Lin, Hao Chen, Le Ni, et al.Pageof 274